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AN ENZYMATIC HORMESIS BOX
MICHAEL GRINFELD
Abstract. We present a simple enzymatic system that is capable of a biphasic response under
competitive inhibition. This is arguably the simplest system that can be said to be hormetic.
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1. Introduction
Though 21st century biology is excellent in collecting data, and very good at translating these data
into therapeutical interventions, it is less good at identifying principles of biological organisation.
It has long been suggested (see for example [3]) that hormesis is a principle of biological organisation.
Whether it is or is not, which is a highly controversial matter as we discuss below, it would be
useful to present simple mechanisms at any level of biological organisation that allow for hormesis.
The present paper takes no position in the heated debate about hormesis and restricts itself to
suggesting an enzymatic “hormesis box”, which might be of independent interest to students of
enzymology.
2. An introduction to hormesis
To quote Wikipedia [9], Hormesis “is any process in a cell or organism that exhibits a biphasic
response to exposure to increasing amounts of a substance or condition.”
We have chosen this definition as it is “ethically neutral”: it makes no claim about the substance
or condition being beneficial or noxious (injurious).
A typical hormesis dose-response curve which is not so ethically neutral is shown in Figure 1.
Here the agent is assumed to be injurious and by a hormetic response in such a situation one
(contentiously) means a response in which an injurious agent in small concentration confers benefits
on the organism; we chose to label the axes in this way to alert the reader to the crux of the
controversy.
In Figure 1 LNT stands for “Linear-No-Threshold”, the basis of much health and safety legisla-
tion. If instead of “noxious” one puts “beneficial” (as in anti-cancer drugs), one should reflect the
hormetic and the LNT responses around the abscissa, both, again, debatable statements
To see the fervour with which the merits and demerits of hormesis as a general principle of or-
ganisation are discussed, consult, for example [7]. In our opinion, the clearest (though partisan)
analysis of the difficulties with hormesis is in [8][Ch. 3]; that chapter is entitled “Hormesis Harms:

































Figure 1. A hormetic dose response curve.
.
Shrader-Frechette distinguishes three different assertions: [H], [HG] and [HD], and says that [H]
is trivially true, [HG] is demonstrably false, and [HD] is ethically and scientifically questionable.
Here
• [H]: (In a particular biological context) there exists an endpoint (an observable) for which
a noxious agent exhibits a beneficial effect at low concentrations;
• [HG]: [H] is generalizable across different biological contexts, endpoints measured, and
classes of chemicals;
• [HD]: [H] should be the default assumption in the risk-assessment [and hence in risk-
regulation] processes.
We comment that methodologically it is not clear by what criteria [HG] can be derived from
instances of [H]: what does “generalizable” really mean? and that [HD] cannot follow from [HG],
no matter how much money it saves to a particular industry; LNT will always be much better
equipped to withstand legal challenges.
However, the impetus for the present work is Shrader-Frechette’s statement that [H] is “trivially
true”. While Shrader-Frechette admits that [H] is well documented across plant, fungal and animal
kingdoms, there must arise the question why this should be the case.
Our tentative answer is that hormesis must hitch a ride on some very general principle (or principles)
of biological organisation and does not make this principle (or these principles) fitness-reducing.
3. A simple enzymatic model of hormesis
We consider a system comprised of an enzyme E, a substrate S, a product P and an inhibitor I.
By hormesis in such a system we mean that the rate of production of P should increase on adding
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sufficiently small amounts of the inhibitor. Obviously, arbitrarily complex mechanisms leading to
hormesis can be devised, involving, for example, additional transcription of genes encoding the
enzyme E. We aim here for maximal simplicity and ask what frequently encountered mechanism
can be superimposed on a single enzyme confronted with a (competitive) inhibitor so that the
system is hormetic.
We start with the indisputable fact that many proteins exist in a dimeric form (there is even
a special BTB “born-to bind” domain!) [5]. The intuition behind the mechanism that we are
proposing is as follows: in the absence of the inhibitor, most molecules of the enzyme E are to be
found in the inert, dimer form E2. In addition to combining with the enzyme at its active site, the
inhibitor also causes the dissociation of the dimer, this making more active enzyme available for
the production of P .


























k10⇀ 2E + I. (1d)
We assume that the substrate S is in constant supply. We would like to understand under what
conditions on the the rate of production of P , i.e. the quasi-steady state concentration of the
complex ES increases as we add a small amount of the inhibitor.
Below we denote concentrations of species by square brackets enclosing the symbol of the species.
The system (1) and the theory of enzyme kinetics [1] implies that we need to find the expression for
the concentration of ES from the following system of two conservation laws for the total amount
of the enzyme and the inhibitor,
[E0] = [E] + 2[E2] + [EI] + [ES] + 2[E2I], (2a)
[I0] = [I] + [EI] + [E2I], (2b)
and the four equations we get by making quasi-steady state assumptions for ES, EI and E2I:
k3[E][I] = k4[EI], (3a)
k5[E][S] = (k6 + k7)[ES], (3b)
k8[E2][I] = (k9 + k10)[E2I], (3c)
k1[E]
2 = 2k2[E2] + 2k10[E2I]. (3d)
Solving the system of equations (2)–(3) purely symbolically is a formidable task as the scheme
(1) involves ten kinetic constants k1, . . . , k10, and we also have to take into account stoichiometric
constraints. Of course, 4 of the kinetic constants can be absorbed and non-dimensionalisation
will get rid of one of the stoichiometric constraints. The remaining system will still have eight
parameters, and as the goal of the paper is not an exhaustive analysis of (2)–(3), we make rather
crude simplifications in order to exhibit the possibility of hormesis in this system. Intuitively, to
get a hormetic response, we need both k1 and k10 to be “large”, so that without inhibitor most
enzyme is in dimeric form E2, and, once inhibitor is added, it causes enough release of the active
enzyme E from the pool sequestered in the dimer to raise the level of production of P . To exhibit
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the relation between the strengths of the two processes that results in a hormetic response, we
simply put
k2 = k3 = · · · = k9 = 1,
and take [E0] = 1, i.e. set the total concentration of enzyme equal to one, and assume that the
concentration of the substrate S is constant, and satisfies [S]  [E0]; in our computations below
we use [S] = 10.
Thus we have a system of six equations in the variables [E], [ES], [EI], [E2], E2I] and [I] with




we are really only interested in [ES] as a function of these parameters. Obtaining an explicit
formula for [ES] (satisfying 0 < [ES] < [E0] = 1), is still nontrivial, but a univariate polynomial
satisfied by [ES] with coefficients depending on k1, k10 and [I0], P ([ES], [I0], k1, k10) can be easily
obtained in MAPLE [4] using the Groebner package (it is denoted by poly in the code in Appendix
A. For more information on Gröbner bases that have proved to be very useful in solving polynomial
equations of enzyme kinetics, the reader is referred to [2].
Solving P ([ES], [I0], k1, k10) = 0, we have that the rate of production of P in the absence of the







Now we use a regular perturbation expansion: we write
[ES] = r0 + r1[I0] + O([I0]
2).
Hence hormesis is equivalent to r1 > 0. Computing r1 shows that the condition for hormesis can
be written in a very elegant way:
(4) k1 > k1,crit :=
7k210 + 2k10 − 5
(k10 − 1)2
, k10 > 1.
From (4) it is clear that hormesis is not possible for any value of k10 is k1 ≤ 7. In the simulation
below we choose k1 = 40, k10 = 50 which clearly falls in the hormetic regime of (4), and from
P ([ES], [I0], 40, 50) = 0 find the unique value of [ES] in [0, 1] as a function of [I0]. The results are
presented in Figure 2, and clearly show biphasic response.
4. Discussion
As observed in the Introduction, in Figure 1 the ordinate is in units of “benefit” to the organism
as most emotionally charged discussions of ethics and philosophy of hormesis are couched in these
terms. We do not commit to interpret the (counterintuitive) increase in the rate of production of
P in our model system as the competitive inhibitor is added to a benefit, being entitled to do so
by our ethically neutral definition of hormesis.
In this short paper we presented a plausibly general mechanism by which a hormetic biphasic
response could be generated in a simple enzymatic system; what made the biphasic response possible
was sequestration of most enzyme in a dimer and the inhibitor-regulated release of the monomers
from the dimer. It would be interesting to know if systems where this mechanism is operational





















Figure 2. The hormetic response in (1); see text for parameter values.
The claim [HG] in ethically neutral terms states that biphasic effects are the norm. If true, this
is in fact as astonishing claim as, in our context, it does not mention the inhibitor ever being
encountered before in the history of a species; it could be a chemical that had been synthesized for
the first time in history just before the exposure experiment.
Many of R. Rosen’s examples of anticipatory systems [6] can be explained away by recourse to an
evolutionary argument: the system behaves in such and such a way (e.g. the product of the first
in a chain of enzymatic reactions leads to an activation of transcription of the last enzyme in the
chain) because such behaviour is “fitter” than its absence (as, in the above example, absence of such
an “anticipatory” effect would lead to a buildup of an intermediate in the chain of reactions), in
which case the description of such a system as “anticipatory” is redundant and has no explanatory
power. Hence an ethically neutral form of [HG], if true, would indicate the existence of intrinsically
anticipatory systems.
Appendix A. Maple code for computations used in this paper
Here we show how to compute the polynomial in [ES], poly and the relation between k1 and k10
(k1crit below). Below ES corresponds to [ES]m etc.
with(Groebner):
# set E0 to 1 and S to 10
# we use I1 instead of I as I is reserved I Maple





# set all constants equal to 1 apart from k1 and k10





e6 := -k1*E^2+k2*2*E2+2*k10*E2I: # more terms here but all zero by QSSA.
F := [e1,e2,e3,e4,e5,e6];
poly:= Basis(F,plex(I1,E,E2,EI,E2I,ES))[1]:
# poly is a 5th order polynomial in ES with coefficients that depend on
# I0, k1 and k10. You need the solution of poly that lies between
# zero and E0.
ab := factor(subs(I0=0,poly)):
r0:= solve(op(1,ab),ES)[1]:
# r0 is the value of ES when I0=0
ac := subs(ES=r0+r1*I0,aa):
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